Stratmann K, Bock H, Filmann N, Fister P, Weber C, Tacke W, Simonis B, Höftmann M, Schröder O, Hausmann J, Zeuzem S, Blumenstein I
First Department of Internal Medicine, Division of Gastroenterology, Johann Wolfgang Goethe-University Hospital, Frankfurt/Main, Germany.
Quality Management Group of Gastroenterologists in Hesse, Gastroenterologie Hessen eG, Frankfurt/Main, Germany.
United European Gastroenterol J. 2018 Aug;6(7):1082-1088. doi: 10.1177/2050640618769713. Epub 2018 Apr 16.
Colorectal cancer (CRC) is the second most common cancer in Germany. Screening colonoscopies are considered an effective tool for early detection and prevention of CRC and are recommended in Germany for citizens over the age of 55. To increase the participation rate for screening colonoscopies, an invitation procedure was initiated in parts of Germany for patients between the ages of 55 and 75 who had never undergone a screening colonoscopy before.
We examined the number of participating patients before, during, and after the invitation procedure and compared the number of the participating patients who received a cover letter with the participating patients from the control group. Additionally, we classified the findings of the colonoscopies including CRC, advanced adenomas, and polyps.
During the invitation period, the participation rate of the invitation group increased from 220 patients to 531 patients compared to 1256 to 1693 in the control group. The increase was significantly greater in patients with cover letters (+141% vs.+35%, < 0.0001). Also, significantly more polyps and adenomas were found in patients from the invitation letter group (254 (+102%) vs. 679 (-9%), < 0.0001).
Our study clearly indicates that personal invitation letters are an effective measure to increase overall participation rates in screening colonoscopies.
结直肠癌(CRC)是德国第二常见的癌症。筛查结肠镜检查被认为是早期发现和预防CRC的有效工具,在德国,建议55岁以上的公民进行此项检查。为了提高筛查结肠镜检查的参与率,德国部分地区启动了一项邀请程序,针对55至75岁且此前从未接受过筛查结肠镜检查的患者。
我们检查了邀请程序实施前、期间和之后参与的患者数量,并将收到附信的参与患者数量与对照组的参与患者数量进行了比较。此外,我们对结肠镜检查的结果进行了分类,包括CRC、进展性腺瘤和息肉。
在邀请期内,邀请组的参与率从220名患者增加到531名患者,而对照组从1256名增加到1693名。收到附信的患者增加幅度显著更大(分别为+141%和+35%,<0.0001)。此外,附信组患者发现的息肉和腺瘤也显著更多(分别为254个(+102%)和679个(-9%),<0.0001)。
我们的研究清楚地表明,个人邀请信是提高筛查结肠镜检查总体参与率的有效措施。